Name: Innate Pharma S.A. (IPHA) Balance Sheet
Creator: FinSpry

Innate Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions EUR

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Innate Pharma S.A. (IPHA) - Annual data in millions EUR
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	66.40	70.61	84.23	103.76	136.79	218.87	167.53
Short-Term Investments	14.37	21.85	17.26	16.08	14.85	0.00	0.00
Cash & Short-Term Investments	80.77	92.46	101.49	103.76	151.64	218.87	167.53
Accounts Receivable	1.64	46.49	3.08	18.42	13.87	13.14	146.64
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.82	5.69	0.00	0.00	6.83	0.00	0.00
Total Current Assets	85.74	148.01	139.83	138.26	173.45	237.61	319.64
Non-Current Assets
Property, Plant & Equipment (Net)	5.13	6.32	8.54	10.17	11.69	11.67	10.22
Long-Term Investments	10.28	9.80	35.12	39.88	38.93	0.00	0.00
Intangible Assets	0.00	0.42	1.55	44.19	46.29	0.00	0.00
Other Non-Current Assets	9.90	10.64	0.15	0.15	29.97	0.09	0.09
Total Non-Current Assets	25.32	36.19	59.47	129.24	133.97	163.76	131.57
Total Assets	111.06	175.19	199.30	267.50	307.42	401.36	451.22
Current Liabilities
Accounts Payable	7.92	8.56	13.66	28.57	20.73	49.50	91.66
Short-Term Debt	8.44	8.45	1.28	29.94	1.37	0.00	0.00
Current Portion of Long-Term Debt	8.44	8.45	1.28	29.94	1.37	0.00	0.00
Deferred Revenue	8.06	13.51	6.56	12.50	13.13	0.00	0.00
Other Current Liabilities	1.33	1.61	10.22	11.40	1.16	21.30	20.99
Total Current Liabilities	32.98	39.64	41.34	79.89	45.49	121.82	196.74
Non-Current Liabilities
Long-Term Debt	22.18	30.61	38.93	11.49	14.19	16.59	3.18
Deferred Tax Liabilities	0.00	9.01	8.57	5.03	7.09	0.00	0.00
Other Non-Current Liabilities	0.27	0.60	52.99	46.96	0.22	0.00	10.67
Total Non-Current Liabilities	69.24	92.66	103.81	80.17	105.96	62.12	87.24
Total Liabilities	102.23	123.29	145.14	133.74	151.45	183.95	283.98
Stockholders' Equity
Common Stock	4.19	4.04	4.01	3.98	3.95	0.00	0.00
Retained Earnings	-386.36	-336.89	-330.32	-272.21	-220.46	-155.67	-134.79
Accumulated Other Comprehensive Income	0.03	0.50	0.82	0.46	0.36	-0.47	-1.10
Additional Paid-in Capital	390.98	384.26	379.64	375.22	372.13	369.62	299.93
Minority Interest	0.00	0.00	-58.10	-52.81	0.00	0.00	0.00
Shares Outstanding	83.81	80.84	79.54	79.54	0.00	0.00	0.00
Total Stockholders' Equity	8.83	51.90	54.15	107.44	155.98	217.42	167.24
Total Liabilities & Equity	111.06	184.21	199.30	267.50	307.42	401.36	451.22